Answers are grounded in this paper and cite their sources.
BSG, OAGB, and BRYGB have very good to excellent midterm outcomes for patients with super obesity and super-super obesity, whereas RYGB and SG have average outcomes at 3 years. There is a need for multicenter, long-term, and prospective studies to be performed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Bhandari et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: